Ole Hudowenz

Mr. Ole Hudowenz


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
OHOle Hudowenz
Ole Hudowenz
PKPhilipp Klemm
Philipp Klemm
ULUwe Lange
Uwe Lange
ARAndreas Rolf
Andreas Rolf
HSHeinz-Peter Schultheiss
Heinz-Peter Schultheiss
FWFranz Wegner
Franz Wegner
Background: Viral genesis is the most common cause of myocarditis. COVID-19-associated myocarditis seems to be a notable extrapulmonary manifestation, which may result in the need for a different treatment. There has been no positive polymerase chain reaction (PCR) testing of SARS-CoV-2 in heart specimens, thus far. Case summary: A 48-year-old male patient presented with fever, dyspnoea, and haemoptysis. Laboratory findings showed highly elevated inflammatory and cardiac damage markers. Thoracic computed tomography (CT) revealed bilateral, patchy peripheral ground-glass opacities with a crazy-paving pattern, focal consolidations, and mild pleural effusions. Cardiac imaging with echocardiography and magnetic resonance imaging (MRI) detected a reduced biventricular function. MRI additionally showed myocardial oedema and late gadolinium enhancement. Lung and heart biopsies were performed, revealing alveolitis with necrosis and acute lymphocytic myocarditis. Testing for usual cardiotropic viruses was negative, and no aspects of vasculitis or granuloma could be found. Due to fulfilling the criteria, the patient was diagnosed with rheumatic vasculitis. Treatment with cyclophosphamide and steroids was initiated. Later, the patient reported a history of travel to Tyrol in mid January. Consequently, PCR testing for SARS-CoV-2 was performed, which was positive in the heart specimen. Immunosuppressive treatment was discontinued. During a follow-up visit at the end of April, the patient’s recovery was stable. Discussion: In COVID-19 infections, myocardial inflammation can be present as an extrapulmonary manifestation. Positive PCR testing confirms myocardial invasion of the virus. Imaging and laboratory studies correlate with the histopathological findings, and thus should be performed in COVID-19 patients who are suspicious for myocarditis. Supportive treatment with steroids may be useful in these patients.

1 January 2020 in International Journal of Hyperthermia
Verified
Journal Article
Open access
PKPhilipp Klemm
Philipp Klemm
MEMarkus Eichelmann
Markus Eichelmann
IAIris Aykara
Iris Aykara
OHOle Hudowenz
Ole Hudowenz
GDGabriel Dischereit
Gabriel Dischereit
ULUwe Lange
Uwe Lange
Aim of this randomized controlled trial was to evaluate the effects of serial locally applied water-filtered infrared A radiation (sl-wIRAR) in patients with axial spondyloarthritis (axSpA). axSpA ...

4 May 2022 in European Journal of Physiotherapy
Verified
Journal Article
Closed access
PKPhilipp Klemm
Philipp Klemm
OHOle Hudowenz
Ole Hudowenz
TAThomas Asendorf
Thomas Asendorf
GDGabriel Dischereit
Gabriel Dischereit
UMUlf Müller-Ladner
Ulf Müller-Ladner
ITIngo H. Tarner
Ingo H. Tarner
Objectives: Multimodal rheumatologic complex therapy (MRCT) delivers various modalities of physical therapy (PT) to patients with rheumatic diseases. We conducted a monocentric retrospective analysis of the effects of MRCT on pain and disease activity in patients with primary (PFM) and secondary fibromyalgia (SFM). Methods: 102 treatment episodes (N) applied to 83 patients (n) with PFM (N = 50;n = 39) and SFM (N = 52,n = 44) were analysed. Of the latter, 23 had rheumatoid arthritis (RA) and 21 spondyloarthritis (SpA). We evaluated changes in pain intensity, functional status and disease activity before and after a MRCT episode. In addition, we assessed influences of various patient characteristics and analysed treatment responses in PFM and SFM. Results: MRCT resulted in significant reduction of pain (NRS,p < 0.0001) and disease activity (FIQ,p = 0.001). In SFM, disease activity of the underlying disease (i.e. RA or SpA) was significantly reduced. Various aspects of the disease did not have a significant effect on the outcome parameters. Treatment effects were not significantly different in PFM and SFM. Conclusion: MRCT significantly decreases pain and disease activity in patients with FM, irrespective of the course of disease, and is equally effective in both PFM and SFM, thus underlining the importance of PT in the treatment of FM.

26 September 2024 in Clinical Transplantation
Verified
Journal Article
Closed access
OHOle Hudowenz
Ole Hudowenz
MNMartin Nitschke
Martin Nitschke
HLHryhoriy Lapshyn
Hryhoriy Lapshyn
PMPhilip Muck
Philip Muck

11 August 2021 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
FWFranz Wegner
Franz Wegner
SBSophie Biedermann
Sophie Biedermann
OHOle Hudowenz
Ole Hudowenz

20 November 2024 in Kidney International
Verified
Journal Article
Closed access
OHOle Hudowenz
Ole Hudowenz
NGNiklas Gebauer
Niklas Gebauer